Generics US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories, filed an Abbreviated New Drug Application with the US Food and Drug Administration seeking approval to market a generic version of pharma behemoth Pfizer's (NYSE: PFE) Pristiq (desvenlafaxine succinate) extended-release tablets, 50mg and 100mg, which is indicated for the treatment of major depressive disorder (MDD) in adults. 26 June 2012